Alleviant Health Centers
PsychiatricNavigating the complex landscape of mental healthcare investment presents a unique challenge for prospective franchise owners, often fraught with concerns about market volatility, operational complexity, and the ability to deliver truly impactful patient outcomes. The persistent problem of access to timely and effective mental health services, with industry averages for new patient referrals stretching from two to six months, creates a significant barrier for individuals seeking crucial support and a substantial market void for innovative solutions. Alleviant Health Centers franchise emerges as a compelling response to this critical need, positioning itself as a transformative force within the mental health sector by offering rapid access to care, guaranteeing new patient referrals within seven days, and pioneering a precision-driven approach to brain health. Founded in 2017 by Brian Mears, DNAP, APRN, CRNA, PMHNP-BC, a distinguished psychiatric nurse practitioner, educator, and national thought leader in Objective Psychiatry, Alleviant Health Centers was established with a clear mission to optimize mental performance, prevent mental illness, and deliver highly effective interventions that improve impaired brain function, ultimately empowering individuals to thrive. While some records indicate a founding year of 2018, the 2017 date is more consistently cited across comprehensive research, anchoring the brand’s origin in a period of burgeoning demand for specialized mental health solutions. The company’s corporate headquarters are strategically located in Little Rock, Arkansas, serving as the operational and innovation hub for its expanding network. Brian Mears currently serves as the President and CEO of Alleviant Health Centers, maintaining a direct leadership role in the company’s strategic direction. A significant leadership evolution occurred in August 2025, with Kyla Farler, previously the Chief Financial Officer, being promoted to President to oversee daily operations and company management, allowing Mears to strategically shift his focus to national expansion, cultivating strategic partnerships, and advancing psychiatric and neurophysiological innovations across the organization. Alleviant Health Centers differentiates its offering through an "integrative holistic behavioral health" model and its proprietary "Objective Psychiatry" methodology, which uniquely leverages spectral EEG (sEEG) brainwave data to personalize treatment plans for each patient, moving beyond conventional diagnostic approaches. This innovative approach underpins a comprehensive suite of services, including traditional psychiatry, therapy, health coaching, personalized medication management, and cutting-edge advanced treatments such as Ketamine Infusion Therapy, Nasal Ketamine, Transcranial Magnetic Stimulation (TMS), and Personalized TMS (PrTMS®), ensuring a multi-faceted approach to brain health. The company began offering the Alleviant Health Centers franchise opportunity in 2018, and as of the most recent data, there are 3 total U.S. franchised units operating under this specialized model, reflecting an initial, focused expansion through franchising. However, the overall growth trajectory of Alleviant Health Centers, encompassing corporate-owned and partnered clinics, has been substantially more aggressive and widespread, indicating a robust internal growth strategy alongside its measured franchise rollout. By June 2020, Alleviant Health Centers had already grown to employ approximately 50 individuals in its Little Rock headquarters and another 50 staff members across its clinics located in California, Colorado, Florida, Ohio, and Tennessee, demonstrating early multi-state operational capacity. The company’s ambitious expansion plans continued through 2020, with new clinics slated to open in Conway, Arkansas; northwest Arkansas; and Aurora, Colorado, further extending its geographic footprint. By April 2020, Alleviant Health Centers had established a "growing network of clinics in six states, including multiple clinics in Arkansas," showcasing a rapid scaling of its clinical operations. More recently, in March 2024, Alleviant Integrated Mental Health announced the opening of its eighth location within Arkansas, situated in Bryant, specifically citing this expansion as a direct response to Bryant and Benton being among the fastest-growing communities in Arkansas, underscoring a data-driven approach to site selection. This rapid expansion culminated in a significant milestone by October 2025, when Alleviant Health Centers celebrated the grand opening of its 10th location nationwide, marking its inaugural entry into Nevada with a new clinic in Henderson, highlighting its commitment to broad national coverage. Current operational Alleviant locations are strategically distributed across Arkansas, including Bentonville, Bryant, Conway, Fayetteville, Fort Smith, North Little Rock, and Rogers, demonstrating a strong regional presence in its home state. Further expansion is already in motion, with upcoming clinic locations planned for Omaha, Nebraska, and Des Moines, Iowa, signaling continued penetration into new Midwestern markets. The overarching vision for Alleviant Health Centers extends beyond national borders, as the company is actively "growing across the United States and preparing for global outreach," driven by its mission to bring brain-based, whole-person care globally. This ambitious global outreach underscores the significant growth trajectory and long-term vision of the brand, positioning the Alleviant Health Centers franchise as a potentially high-impact investment within a rapidly expanding and critically important healthcare segment. The total addressable market for this category is substantial, with the US Mental Health and Substance Abuse Services industry alone generating approximately $50 billion in combined annual revenue across over 17,000 facilities, and the broader industry, including ancillary services, exceeding $300 billion in revenue, providing a vast landscape for the Alleviant Health Centers franchise to capture market share through its differentiated services. The U.S. behavioral health market, a core segment for Alleviant, was valued at $87.82 billion in 2024 and is projected to grow significantly to $132.46 billion by 2032, exhibiting a robust Compound Annual Growth Rate (CAGR) of 5.3% during this forecast period, further validating the strategic importance of this franchise opportunity.
The broader industry landscape in which the Alleviant Health Centers franchise operates is characterized by significant market expansion and evolving consumer demands, making it a highly attractive sector for strategic investment. The US Mental Health and Substance Abuse Services market size was valued at $32.2 billion in 2025 and is projected to reach $33.2 billion in 2026, demonstrating a consistent upward trend. This market segment experienced a Compound Annual Growth Rate (CAGR) of 4.3% between 2020 and 2025, accelerating to a 5.1% CAGR between 2021 and 2026, with a specific increase of 4.3% in 2025 alone, underscoring its dynamic growth. Beyond this specific segment, the overall U.S. Mental Health and Substance Abuse Services industry, comprising over 17,000 facilities, commands a combined annual revenue of approximately $50 billion, and when ancillary services are factored in, the broader industry revenues exceed an impressive $300 billion, illustrating the sheer scale of opportunity. The U.S. behavioral health market, a direct focus for the Alleviant Health Centers franchise, was valued at a substantial $87.82 billion in 2024. This market is projected to expand significantly from $92.14 billion in 2025 to $132.46 billion by 2032, maintaining a robust Compound Annual Growth Rate (CAGR) of 5.3% over this forecast period, indicating sustained and substantial demand. Within this growth, the inpatient hospital treatment segment is projected to grow at the fastest CAGR of 6.09%, while the patient segment is poised to grow at an even faster CAGR of 6.96%, reflecting diverse growth drivers within behavioral health. On a global scale, the mental health services market was valued at $0.42 billion in 2023 and is projected to reach $0.60 billion by 2033, growing at a CAGR of 3.9% from 2024 to 2033, demonstrating a worldwide increase in the prioritization of mental well-being. Furthermore, the broader health and wellness industry, which encompasses mental health, is projected to reach a staggering $7 trillion globally in 2025, highlighting a pervasive societal shift towards holistic well-being. Key consumer trends are significantly driving this demand, with a growing focus on integrative medicine that treats the root causes of disease and acknowledges the profound connection between mind, body, and spirit, directly aligning with Alleviant’s "integrative holistic behavioral health" model. The demand for mental health services has reached an all-time high and continues its upward trajectory, notably exacerbated by global events such as the COVID-19 pandemic, which led to a marked rise in the need for services for mood disorders related to fear and uncertainty. A critical consumer pain point that the Alleviant Health Centers franchise directly addresses is the notoriously long wait times for therapist and psychiatrist appointments, often extending to several months, which Alleviant counteracts by guaranteeing to see new patient referrals within seven days, providing a distinct competitive advantage. The digital transformation of healthcare, particularly telehealth, has profoundly impacted mental health services, with virtual therapy sessions offering remote access to care and patients increasingly utilizing self-management platforms, virtual therapy, and mobile applications, which Alleviant incorporates through its telebehavioral professionals. Demographic needs further underscore market demand; in 2022, the highest prevalence of mental health conditions (36.20%) was observed among young adults aged 18 to 25, indicating a significant need among younger populations. Additionally, 37.1% of women and 29.9% of men reported high levels of anxiety in 2022/23, pointing to widespread mental health challenges across adult demographics. These secular tailwinds, including increased awareness, destigmatization, and technological advancements in brain health diagnostics and treatment, are fundamentally benefiting brands like Alleviant Health Centers franchise that are at the forefront of innovation. The industry category attracts franchise investment due to its critical and growing demand, resilience, and the opportunity to make a significant social impact while achieving financial returns. While the competitive dynamics of the mental health sector can appear fragmented due to over 17,000 facilities, Alleviant Health Centers differentiates itself through its "Objective Psychiatry" and rapid access model, aiming to lead consolidation through specialized, high-quality care. Macro forces such as the global mental health crisis, an aging population requiring specialized care, increased societal stress, and continuous technological advancements in diagnostics and treatment create an immense opportunity for the Alleviant Health Centers franchise to establish and expand its market leadership.
For prospective franchisees evaluating the Alleviant Health Centers franchise, the financial commitment represents a significant investment in a specialized and high-growth healthcare sector. The initial franchise fee for Alleviant Health Centers is $100,000, which positions it at the higher end when compared to the typical franchise fees across various industries, which often range from $30,000 to $60,000. This premium fee reflects the specialized nature of the services offered, the proprietary technology involved in "Objective Psychiatry," and the comprehensive support infrastructure provided by Alleviant. The estimated total initial investment required to open an Alleviant Health Centers franchise ranges from $253,000 to $842,500, a broad spectrum that is influenced by several critical factors. This investment spread can be attributed to variables such as the specific geographic location chosen for the clinic, which impacts real estate costs and market-specific build-out expenses, the extent of leasehold improvements required for the facility, and the specific model or scale of services a franchisee opts to implement. For instance, a larger clinic offering a full suite of advanced treatments like Ketamine Infusion Therapy and PrTMS® would naturally incur higher initial costs compared to a more streamlined operation. To secure an Alleviant Health Centers franchise, the minimum liquid capital required is $80,000, representing the accessible cash an investor must possess to cover initial startup costs and ensure operational liquidity during the early stages of the business. This liquid capital requirement can also be influenced by the aforementioned factors of location, build-out costs, and the chosen operational model, necessitating thorough financial planning. Beyond the initial investment, franchisees are subject to ongoing fees that impact the total cost of ownership and long-term profitability. A notable component is the royalty fee, which stands at 20% of monthly sales, a figure that is considerably higher than the industry average for many franchise systems, which typically range from 4% to 8%. This elevated royalty rate underscores the perceived value of Alleviant’s brand, proprietary methodologies, ongoing innovation in brain health, and comprehensive operational support. Additionally, franchisees "could be required to pay a marketing fee of their monthly sales," contributing to a collective advertising fund designed to enhance brand visibility and drive patient acquisition across the network. While a specific percentage for this marketing fee is not disclosed in the available information, its existence adds another layer to the ongoing financial commitments for an Alleviant Health Centers franchise owner. Analyzing the total cost of ownership, the combination of a $100,000 franchise fee, an initial investment range spanning up to $842,500, and a substantial 20% royalty rate positions the Alleviant Health Centers franchise as a premium, specialized investment. This financial structure suggests that the brand is targeting sophisticated investors who recognize the high value proposition of operating in a critically important and technologically advanced segment of the healthcare industry. Given the advanced medical nature of its services and the significant financial outlay, this is clearly positioned as a premium franchise investment rather than an accessible or mid-tier opportunity. The corporate backing and ambitious growth plans, with Brian Mears remaining CEO and focusing on national expansion and innovations while Kyla Farler assumes the presidency in August 2025, indicate a well-resourced and forward-thinking parent company committed to supporting its network. While specific financing considerations such as SBA eligibility or veteran incentives are not detailed in the provided data, the substantial investment suggests that franchisees would likely explore a range of financing options, including commercial loans, to fund their Alleviant Health Centers franchise venture.
The operating model for an Alleviant Health Centers franchise is designed to deliver "integrative holistic behavioral health" and "Objective Psychiatry" through a comprehensive suite of advanced mental healthcare services, requiring a sophisticated and patient-centric daily operational flow. Franchisees will be deeply involved in managing the delivery of psychiatry, therapy, and health coaching, alongside specialized treatments such as personalized medication management. A key differentiator in daily operations is the provision of cutting-edge treatments including Ketamine Infusion Therapy, Nasal Ketamine, Transcranial Magnetic Stimulation (TMS), and Personalized TMS (PrTMS®), which necessitate specialized equipment, protocols, and trained personnel. Central to Alleviant’s operational philosophy is the utilization of spectral EEG (sEEG) brainwave data to personalize treatment plans, ensuring that daily clinical decisions are data-driven and tailored to individual patient needs. A critical operational commitment for every Alleviant Health Centers franchise is the guarantee to see new patient referrals within seven days, a standard that dramatically outperforms the industry average of two to six months and requires highly efficient scheduling, intake processes, and staffing models. This rapid access to care is a core tenet of the brand’s patient-first approach and a significant competitive advantage. The staffing requirements for an Alleviant Health Centers franchise are robust, necessitating a team of highly skilled professionals to deliver its specialized services. This includes psychiatric nurse practitioners (like founder Brian Mears), licensed therapists, health coaches, and potentially medical staff trained in advanced procedures such as Ketamine infusion and TMS, indicating a significant investment in human capital. The labor model will focus on clinical excellence and patient experience, supported by administrative and front-desk staff to manage the guaranteed rapid access and closed-loop communication system with referring providers and families. While specific format options like drive-thru or kiosk models are not applicable to this medical franchise, the company operates through physical clinic locations, as evidenced by its $8.3 million headquarters expansion in Little Rock, which renovated 30,000 square feet of leased space, and the opening of its eighth Arkansas location in Bryant and 10th nationwide location in Henderson, Nevada. This implies a standard clinic format designed for patient comfort and the delivery of specialized treatments. New franchisees embarking on the Alleviant Health Centers franchise journey receive a comprehensive initial training program, typically spanning two weeks, designed to equip them with the necessary knowledge and skills to successfully operate their clinic. This intensive training takes place at Alleviant’s corporate location, situated in Little Rock, Arkansas, providing hands-on experience and immersion in the company’s operational standards, clinical protocols, and brand culture. The training covers essential operational aspects of the business, from patient intake and scheduling to the implementation of "Objective Psychiatry" and advanced treatment modalities. Beyond the initial training, Alleviant Health Centers offers extensive ongoing support to its franchise network, recognizing the complex and evolving nature of mental healthcare. Franchisees gain access to a rich library of resources, which includes meticulously developed marketing materials and best practices, all strategically designed to aid in business development, patient acquisition, and brand consistency. The corporate team’s approach to project management is highly structured, coordinating resources, timelines, and deliverables to consistently meet deadlines and quality standards, utilizing proven systems and communication protocols that benefit the entire network. Furthermore, Alleviant emphasizes maintaining rigorous compliance standards and quality certifications, which is crucial in the healthcare sector, to establish and maintain competitive advantages, ensuring that each Alleviant Health Centers franchise operates at the highest level of clinical excellence and regulatory adherence. While specific details on territory structure and exclusivity are not provided, the company's strategic expansion into specific fast-growing communities like Bryant, Arkansas, and new states like Nevada, Nebraska, and Iowa, suggests a methodical approach to market penetration. The aggressive growth trajectory, with plans for global outreach and 10 locations nationwide by October 2025, indicates an expectation or strong encouragement for multi-unit development among capable franchisees, though explicit requirements are not stated. Given the specialized medical nature of the services, an owner-operator model or a franchisee with significant healthcare management experience is strongly implied, rather than a purely absentee ownership structure, to ensure clinical oversight and operational fidelity.
When evaluating the Alleviant Health Centers franchise opportunity, a crucial aspect for any prospective investor is understanding the financial performance of existing units. However, it is important to state clearly that Item 19 financial performance data is NOT disclosed in the current Franchise Disclosure Document, meaning Alleviant Health Centers does not provide specific earnings claims such as average revenue per unit, median revenue, or profit margins. This non-disclosure is further reinforced by the company's CEO, Brian Mears, who declined to reveal revenue figures in a June 2020 article, maintaining a consistent stance on not publicly sharing unit-level financial performance. The company explicitly states, "While we cannot and do not make any guarantees or projections of profitability or earnings, we can provide you with the resources necessary to make an informed decision," indicating that while they will support due diligence, direct financial performance representations are not part of their standard disclosure. Despite the absence of specific Item 19 data for the Alleviant Health Centers franchise, valuable insights can be gleaned from broader industry benchmarks and the company's robust growth trajectory. The US Mental Health and Substance Abuse Services industry, comprising over 17,000 facilities, generates a combined annual revenue of approximately $50 billion, suggesting a significant revenue potential for individual units operating within this vast market. Furthermore, the US behavioral health market, a core segment for Alleviant, was valued at $87.82 billion in 2024 and is projected to grow substantially to $132.46 billion by 2032, exhibiting a Compound Annual Growth Rate (CAGR) of 5.3%. These large market sizes and sustained growth rates indicate a strong underlying demand for mental health services, which could translate into robust revenue streams for well-managed Alleviant Health Centers franchise locations. The company's unique competitive positioning, characterized by its "Objective Psychiatry" methodology utilizing spectral EEG (sEEG) brainwave data, coupled with advanced treatments like Ketamine Infusion Therapy, Nasal Ketamine, Transcranial Magnetic Stimulation (TMS), and Personalized TMS (PrTMS®), positions it to potentially command premium pricing and attract a higher volume of patients seeking specialized, cutting-edge care. The commitment to guaranteeing new patient referrals within seven days, a stark contrast to the industry average of two to six months, is a powerful differentiator that can significantly drive patient volume and, consequently, revenue for each Alleviant Health Centers franchise. This operational efficiency in patient access could lead to higher utilization rates and sustained client bases. Moreover, the substantial corporate investment in Alleviant Health Centers signals strong internal confidence in the business model's scalability and profitability. In April 2020, the company announced an $8.3 million expansion of its headquarters in Little Rock, involving
